|
1
|
Mocarska A, Staroslawska E,
Zelazowska-Cieślińska I, Łosicki M, Stasiewicz D, Kieszko D and
Burdan F: Epidemiology and risk factors of the cervical squamous
cell carcinoma. Pol Merkur Lekarski. 33:101–106. 2012.(In Polish).
PubMed/NCBI
|
|
2
|
Yung KW, Yung TT, Chung CY, Tong GT, Liu
Y, Henderson J, Welbeck D and Oseni S: Principles of cancer
staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
3
|
Chiappetta C, Lendaro E, Cacciotti J,
Zaralli R, Puggioni C, Migliore G, Petrozza V, Rocca CD and Di
Cristofano C: The 16, 18, and 45 HPV infection in high grade
squamous cervical lesions in primary hr-HPV test screening program.
Eur J Gynaecol Oncol. 36:722–725. 2015.PubMed/NCBI
|
|
4
|
Smith JS, Lindsay L, Hoots B, Keys J,
Franceschi S, Winer R and Clifford GM: Human papillomavirus type
distribution in invasive cervical cancer and high-grade cervical
lesions: a meta-analysis update. Int J Cancer. 121:621–632. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mzarico E, Gómez-Roig MD, Guirado L,
Lorente N and Gonzalez-Bosquet E: Relationship between smoking, HPV
infection, and risk of Cervical cancer. Eur J Gynaecol Oncol.
36:677–680. 2015.PubMed/NCBI
|
|
6
|
Zacapala-Gómez AE, Del Moral-Hernández O,
Villegas-Sepúlveda N, Hidalgo-Miranda A, Romero-Córdoba SL,
Beltrán-Anaya FO, Leyva-Vázquez MA, Alarcón-Romero LC and
Illades-Aguiar B: Changes in global gene expression profiles
induced by HPV 16 E6 oncoprotein variants in cervical carcinoma
C33-A cells. Virology. 488:187–195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poljak M, Kocjan BJ, Oštrbenk A and Seme
K: Commercially available molecular tests for human
papillomaviruses (HPV): 2015 update. J Clin Virol. 76(Suppl 1):
S3–S13. 2015.PubMed/NCBI
|
|
8
|
Zanier K, ould M'hamed ould Sidi A,
Boulade-Ladame C, Rybin V, Chappelle A, Atkinson A, Kieffer B and
Travé G: Solution structure analysis of the HPV16 E6 oncoprotein
reveals a self-association mechanism required for E6-mediated
degradation of p53. Structure. 20:604–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang G, Sun L, Li Z, Si L, Song T, Huang
C and Zhang W: HPV-16E6 can induce multiple site phosphorylation of
p53. Oncol Rep. 21:371–377. 2009.PubMed/NCBI
|
|
10
|
Bernard X, Robinson P, Nominé Y, Masson M,
Charbonnier S, Ramirez-Ramos JR, Deryckere F, Travé G and
Orfanoudakis G: Proteasomal degradation of p53 by human
papillomavirus E6 oncoprotein relies on the structural integrity of
p53 core domain. PLoS One. 6:e259812011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee CJ, Suh EJ, Kang HT, Im JS, Um SJ,
Park JS and Hwang ES: Induction of senescence-like state and
suppression of telomerase activity through inhibition of HPV E6/E7
gene expression in cells immortalized by HPV16 DNA. Exp Cell Res.
277:173–182. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
D'Costa ZJ, Jolly C, Androphy EJ, Mercer
A, Matthews CM and Hibma MH: Transcriptional repression of
E-cadherin by human papillomavirus type 16 E6. PLoS One.
7:e489542012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dionne KR, Zhuang Y, Leser JS, Tyler KL
and Clarke P: Daxx upregulation within the cytoplasm of
reovirus-infected cells is mediated by interferon and contributes
to apoptosis. J Virol. 87:3447–3460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
White EA, Kramer RE, Tan MJ, Hayes SD,
Harper JW and Howley PM: Comprehensive analysis of host cellular
interactions with human papillomavirus E6 proteins identifies new
E6 binding partners and reflects viral diversity. J Virol.
86:13174–13186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niebler M, Qian X, Höfler D, Kogosov V,
Kaewprag J, Kaufmann AM, Ly R, Böhmer G, Zawatzky R, Rösl F, et al:
Post-translational control of IL-1β via the human papillomavirus
type 16 E6 oncoprotein: a novel mechanism of innate immune escape
mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog.
9:e10035362013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McCloskey R, Menges C, Friedman A, Patel D
and McCance DJ: Human papillomavirus type 16 E6/E7 upregulation of
nucleophosmin is important for proliferation and inhibition of
differentiation. J Virol. 84:5131–5139. 2010. View Article : Google Scholar : PubMed/NCBI
|
